Blood · 2010 · 98 citations · 36 references
MedicineGeneticsHematologyCell TherapyGene DeliveryGene TherapyAnemiaHematopoietic DevelopmentHematopoietic DifferentiationHematopoietic Stem Cell BiologyRed Blood Cell DisordersSickle Cell DiseaseBeta-thalassemia Gene TherapyGene Delivery To Hematopoietic CellsHematopoietic Stem Cell Gene TransferHemoglobin Synthesis DefectsLentiviral Gene TransferLentiviral Vector EngineeringLentiviral Vector TransductionThalassemia Major
β-Thalassemia major results from severely reduced or absent expression of the β-chain of adult hemoglobin (α₂β₂;HbA). Increased levels of fetal hemoglobin (α₂γ₂;HbF), such as occurs with hereditary persistence of HbF, ameliorate the severity of β-thalassemia, raising the potential for genetic therapy directed at enhancing HbF. We used an in vitro model of human erythropoiesis to assay for enhanced production of HbF after gene delivery into CD34(+) cells obtained from mobilized peripheral blood of normal adults or steady-state bone marrow from patients with β-thalassemia major. Lentiviral vectors encoding (1) a human γ-globin gene with or without an insulator, (2) a synthetic zinc-finger transcription factor designed to interact with the γ-globin gene promoters, or (3) a short-hairpin RNA targeting the γ-globin gene repressor, BCL11A, were tested. Erythroid progeny of normal CD34(+) cells demonstrated levels of HbF up to 21% per vector copy. For β-thalassemic CD34(+) cells, similar gene transfer efficiencies achieved HbF production ranging from 45% to 60%, resulting in up to a 3-fold increase in the total cellular Hb content. These observations suggest that both lentiviral-mediated γ-globin gene addition and genetic reactivation of endogenous γ-globin genes have potential to provide therapeutic HbF levels to patients with β-globin deficiency.
36
Vijay G. Sankaran, Tobias Menne, Jian Xu et al. · Science · 2008 · 902 citations
Medicine, Genetics, Hematology +13
Correction of Sickle Cell Disease in Transgenic Mouse Models by Gene Therapy
Robert Pawliuk, Karen A. Westerman, Mary E. Fabry et al. · Science · 2001 · 579 citations
Medicine, Genetics, Hematology +17